financetom
CPAC
financetom
/
Materials
/
CPAC
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Cementos Pacasmayo S.A.A.CPAC
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Cementos Pacasmayo S.A.A., a cement company, produces, distributes, and sells cement and cement-related materials in Peru.

It operates through three segments: Cement, Concrete, Mortar, and Precast; Quicklime; and Sales of Construction Supplies.

The company's cement and concrete products are used in residential and commercial construction, and civil engineering; ready-mix concrete used in construction sites; concrete precast, such as paving units or paver stones for pedestrian walkways, as well as other bricks for partition walls and concrete precast for structural and non-structural uses; and cement-based products.

It also produces and distributes quicklime for use in steel, food, fishing, and chemical industries. In addition, the company sells and distributes other construction materials manufactured by third parties, such as steel rebar, plastic pipes, and electrical wires.

It sells and distributes its products to other retailers, private construction companies, and government entities through a network of independent retailers and hardware stores.

The company was incorporated in 1949 and is headquartered in Lima, Peru. Cementos Pacasmayo S.A.A.

is a subsidiary of Inversiones ASPI S.A.

Latest News >
--First of Long Island Keeps Quarterly Dividend at $0.21 per Share, Payable July 18 to Shareholders of Record July 10
--First of Long Island Keeps Quarterly Dividend at $0.21 per Share, Payable July 18 to Shareholders of Record July 10
Jun 28, 2024
10:44 AM EDT, 06/28/2024 (MT Newswires) -- Price: 10.11, Change: +0.32, Percent Change: +3.27 ...
Soleno Therapeutics Submits New Drug Application to FDA for Prader-Willi Syndrome Treatment
Soleno Therapeutics Submits New Drug Application to FDA for Prader-Willi Syndrome Treatment
Jun 28, 2024
10:44 AM EDT, 06/28/2024 (MT Newswires) -- Soleno Therapeutics ( SLNO ) said Friday it has submitted a new drug application to the US Food and Drug Administration for approval of DCCR (diazoxide choline) extended-release tablets for the treatment of Prader-Willi syndrome in patients aged 4 and older who have hyperphagia. The FDA has 60 days to decide if the...
AtkinsRealis Unit Reaches Framework Agreement to Support Deployment of Poland's First Small Modular Reactors
AtkinsRealis Unit Reaches Framework Agreement to Support Deployment of Poland's First Small Modular Reactors
Jun 28, 2024
10:47 AM EDT, 06/28/2024 (MT Newswires) -- Candu Energy Inc., an AtkinsRealis ( SNCAF ) company (ATRL.TO), Friday entered into a framework agreement with Orlen-Synthos Green Energy (OSGE) for the planned deployment of a fleet of GE Hitachi Nuclear Energy's BWRX-300 small modular reactors (SMRs) in Poland. Also, the company entered a teaming agreement with OSGE, Aecon ( AEGXF )...
IZEA Worldwide Launches $5 Million Share Buyback Plan
IZEA Worldwide Launches $5 Million Share Buyback Plan
Jun 28, 2024
10:46 AM EDT, 06/28/2024 (MT Newswires) -- IZEA Worldwide ( IZEA ) said Friday its board has approved a share buyback program under which the company may repurchase up to $5 million of its common shares from time to time. The program is subject to market conditions and the company's insider trading windows. Shares of IZEA ( IZEA ) were...
Copyright 2023-2026 - www.financetom.com All Rights Reserved